The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2003
DOI: 10.1124/jpet.102.044263
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(31 citation statements)
references
References 36 publications
0
31
0
Order By: Relevance
“…3A, Lane 3) and generated four major fragments with molecular weights similar to fragments generated by PMN cell proteases. The highly selective neutrophil elastase inhibitor SSR69071 [27] largely inhibited decorin degradation by PMN proteases (reduced by 92%, Lanes 1 and 2 in Fig. 3A and Fig.…”
Section: Resultsmentioning
confidence: 94%
“…3A, Lane 3) and generated four major fragments with molecular weights similar to fragments generated by PMN cell proteases. The highly selective neutrophil elastase inhibitor SSR69071 [27] largely inhibited decorin degradation by PMN proteases (reduced by 92%, Lanes 1 and 2 in Fig. 3A and Fig.…”
Section: Resultsmentioning
confidence: 94%
“…Anal. calcd for C 24 H 15 N 5 O 2 S: C 65.89, H 3.46, N 16.01; found C 65.94, H 3.51, N 16.06. 6-(2-Fluorophenyl)-9-phenylamino-5H-thiazolo [3',2':2, 3]pyrido [4,5-d] 9,158.5,157.7,153.5,151.3,150.0,147.4,141.2,135.6,135.2,131.3,130.6,130.1,129.3,125.0,123.3,121.0,118.3,118.2,117.6,116.1,103.2;IR (KBr) ν max : 3342 (N-H), 1685 (C=O) cm -1 . Anal.…”
Section: Synthesis Of 2-mentioning
confidence: 99%
“…[7] For example, this structural pattern is present in the known antiallergic agent ramastine [8] and human leukocyte elastase inhibitor SSR69071. [9] Therefore, search for new biologically active compounds in this series seems to be quite promising. Owing to these remarkably broad pharmacological properties, a variety of synthetic methods have been reported for the preparation of pyrido[1,2-a]pyrimidinone derivatives.…”
Section: Introductionmentioning
confidence: 99%
“…Based on the identification of cleavage fragment a, we speculated that neutrophil elastase contributed to ␣1-ACT fragmentation in chronic human wounds (valine at position P1 and alanine at position P3). To test this hypothesis, we analyzed the ability of SSR 69071, a potent inhibitor of human neutrophil elastase (IC 50 ϭ 3.9 nmol/liter) (34), to block r␣1-ACT fragmentation in wound exudate. Exudates characterized by high r␣1-ACT degrading and inactivating activity were incubated with SSR 69071 at different concentrations prior to addition of r␣1-ACT and for different times as indicated.…”
Section: Neutrophil Elastase Inhibitor Significantly Increases Stabilmentioning
confidence: 99%